Search

Jake Minh Vu

Examiner (ID: 8807, Phone: (571)272-8148 , Office: P/1618 )

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
1117
Issued Applications
361
Pending Applications
132
Abandoned Applications
637

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7040505 [patent_doc_number] => 20050159395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'NSAID-containing topical formulations that demonstrate chemopreventive activity' [patent_app_type] => utility [patent_app_number] => 11/037224 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6727 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159395.pdf [firstpage_image] =>[orig_patent_app_number] => 11037224 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/037224
NSAID-containing topical formulations that demonstrate chemopreventive activity Jan 18, 2005 Abandoned
Array ( [id] => 5215659 [patent_doc_number] => 20070104740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Self-microemulsifying drug delivery systems of a hiv protease inhibitor' [patent_app_type] => utility [patent_app_number] => 10/596738 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13117 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104740.pdf [firstpage_image] =>[orig_patent_app_number] => 10596738 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/596738
Self-microemulsifying drug delivery systems of a hiv protease inhibitor Dec 22, 2004 Abandoned
Array ( [id] => 5182628 [patent_doc_number] => 20070053974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Stable oral composition' [patent_app_type] => utility [patent_app_number] => 10/583842 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4198 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053974.pdf [firstpage_image] =>[orig_patent_app_number] => 10583842 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/583842
Stable oral composition Dec 22, 2004 Issued
Array ( [id] => 7193491 [patent_doc_number] => 20050163842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Rosiglitazone and metformin formulations' [patent_app_type] => utility [patent_app_number] => 11/021562 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27725 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163842.pdf [firstpage_image] =>[orig_patent_app_number] => 11021562 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/021562
Rosiglitazone and metformin formulations Dec 22, 2004 Abandoned
11/016683 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain Dec 16, 2004 Abandoned
Array ( [id] => 5215714 [patent_doc_number] => 20070104795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Multiphase active ingredient formulation' [patent_app_type] => utility [patent_app_number] => 10/583302 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5882 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104795.pdf [firstpage_image] =>[orig_patent_app_number] => 10583302 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/583302
Multiphase active ingredient formulation Dec 14, 2004 Abandoned
Array ( [id] => 7168197 [patent_doc_number] => 20050201974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Bioadhesive polymers with catechol functionality' [patent_app_type] => utility [patent_app_number] => 11/009327 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11277 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201974.pdf [firstpage_image] =>[orig_patent_app_number] => 11009327 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/009327
Bioadhesive polymers with catechol functionality Dec 8, 2004 Abandoned
Array ( [id] => 7250517 [patent_doc_number] => 20050142193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Galantamine formulations' [patent_app_type] => utility [patent_app_number] => 11/001609 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6066 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142193.pdf [firstpage_image] =>[orig_patent_app_number] => 11001609 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001609
Galantamine formulations Nov 30, 2004 Abandoned
Array ( [id] => 7688786 [patent_doc_number] => 20070105912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Pharmaceutical compositions comprising lercanidipine' [patent_app_type] => utility [patent_app_number] => 10/581128 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21105 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105912.pdf [firstpage_image] =>[orig_patent_app_number] => 10581128 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581128
Pharmaceutical compositions comprising lercanidipine Nov 30, 2004 Abandoned
Array ( [id] => 5193563 [patent_doc_number] => 20070082047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Solid preparation' [patent_app_type] => utility [patent_app_number] => 10/578136 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10609 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082047.pdf [firstpage_image] =>[orig_patent_app_number] => 10578136 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/578136
Solid preparation Nov 3, 2004 Abandoned
Array ( [id] => 7127963 [patent_doc_number] => 20050059707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Stabilization of retinoid compounds' [patent_app_type] => utility [patent_app_number] => 10/972568 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2721 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059707.pdf [firstpage_image] =>[orig_patent_app_number] => 10972568 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/972568
Stabilization of retinoid compounds Oct 24, 2004 Abandoned
Array ( [id] => 5204596 [patent_doc_number] => 20070026077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component' [patent_app_type] => utility [patent_app_number] => 10/575986 [patent_app_country] => US [patent_app_date] => 2004-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2307 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026077.pdf [firstpage_image] =>[orig_patent_app_number] => 10575986 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575986
Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component Oct 13, 2004 Abandoned
Array ( [id] => 7168179 [patent_doc_number] => 20050201972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery' [patent_app_type] => utility [patent_app_number] => 10/962204 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24128 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201972.pdf [firstpage_image] =>[orig_patent_app_number] => 10962204 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/962204
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery Oct 6, 2004 Issued
Array ( [id] => 7010295 [patent_doc_number] => 20050064011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Implantable or insertable medical devices containing phenolic compound for inhibition of restenosis' [patent_app_type] => utility [patent_app_number] => 10/955368 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7479 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064011.pdf [firstpage_image] =>[orig_patent_app_number] => 10955368 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/955368
Implantable or insertable medical devices containing phenolic compound for inhibition of restenosis Sep 29, 2004 Abandoned
Array ( [id] => 7163486 [patent_doc_number] => 20050085498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate' [patent_app_type] => utility [patent_app_number] => 10/947054 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19504 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085498.pdf [firstpage_image] =>[orig_patent_app_number] => 10947054 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/947054
Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate Sep 20, 2004 Abandoned
Array ( [id] => 6938638 [patent_doc_number] => 20050112201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Delayed release dosage forms' [patent_app_type] => utility [patent_app_number] => 10/943356 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17564 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112201.pdf [firstpage_image] =>[orig_patent_app_number] => 10943356 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/943356
Delayed release dosage forms Sep 16, 2004 Issued
Array ( [id] => 6911883 [patent_doc_number] => 20050175641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Percutaneous and perungual delivery system' [patent_app_type] => utility [patent_app_number] => 10/941054 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6156 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175641.pdf [firstpage_image] =>[orig_patent_app_number] => 10941054 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/941054
Percutaneous and perungual delivery system Sep 9, 2004 Abandoned
Array ( [id] => 5601841 [patent_doc_number] => 20060292186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs' [patent_app_type] => utility [patent_app_number] => 10/569316 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7874 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292186.pdf [firstpage_image] =>[orig_patent_app_number] => 10569316 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569316
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs Aug 26, 2004 Abandoned
Array ( [id] => 5193474 [patent_doc_number] => 20070081958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Body care product containing porous silver particles' [patent_app_type] => utility [patent_app_number] => 10/570230 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4514 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20070081958.pdf [firstpage_image] =>[orig_patent_app_number] => 10570230 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/570230
Body care product containing porous silver particles Aug 25, 2004 Abandoned
Array ( [id] => 6982909 [patent_doc_number] => 20050152979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Hydrophobic drug compositions containing reconstitution enhancer' [patent_app_type] => utility [patent_app_number] => 10/925797 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5992 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152979.pdf [firstpage_image] =>[orig_patent_app_number] => 10925797 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/925797
Hydrophobic drug compositions containing reconstitution enhancer Aug 24, 2004 Abandoned
Menu